15 patents currently held
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
1 more record may belong here and awaits a decision; it is not counted.
The next term ends in Nov 2026. from the record
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
9
Ending by 2030
Nov 2026
Next term end
8
Patent families
When these terms end
Held patents by the year their term ends
notable patents
all others
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Nov 2027 · High confidence
Also notable
Ends Nov 2026 · Medium confidence
Also notable
Ends Dec 2027 · High confidence
Optimized Stent Jacket
US 10,070,976
The most cited patent in this portfolio, cited by 98 later US patents, top 5% of utility patents granted in 2018 in our data. Protection runs to 2027.
Bifurcated stent assemblies
US 8,961,586
Cited by 53 later US patents, top 10% of utility patents granted in 2015 in our data, and renewed at every maintenance window due so far. Protection runs to 2026.
Knitted Stent Jackets
US 10,137,015
Cited by 33 later US patents, top 10% of utility patents granted in 2018 in our data, and renewed at 2 of 3 maintenance windows. Protection runs to 2027.
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Feb 13, 2027The maintenance fee for Stent Thermoforming Apparatus and Methods (US 10,376,393) comes due Feb 13, 2027. Unpaid by Aug 13, 2027, it lapses early.
- 4 fees due Mar 10 to 15, 2027 · next Mar 10
- 2 fees due Jun 12 to 19, 2027 · next Jun 12
Recent changes
Nothing was recorded against this company's patents in the last 90 days.
What they patent
The 5 largest of its 8 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Optimized Stent Jacket | 6 in force | to Nov 2028 |
| Stent Thermoforming Apparatus and Methods | 2 in force | to Apr 2035 |
| Bifurcated stent assemblies | 2 in force | to Jul 2029 |
| Handle for two-stage deployment of a stent | 1 in force | to Dec 2041 |
| Methods of Using a Self-Adjusting Stent Assembly and Kits Including Same | 1 in force | to Sep 2039 |
Patents held now
Soonest term end first.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,961,586 | Bifurcated stent assemblies In force · Medium confidence | In force | Medium confidence | |
| US 9,132,003 | Optimized Drug-Eluting Stent Assembly In force · High confidence | In force | High confidence | |
| US 9,782,281 | Stent-Mesh Assembly and Methods In force · Medium confidence | In force | Medium confidence | |
| US 10,070,976 | Optimized Stent Jacket In force · High confidence | In force | High confidence | |
| US 10,406,008 | Optimized Stent Jacket Having Single Fiber Mesh In force · Medium confidence | In force | Medium confidence | |
| US 9,526,644 | Optimized Drug-Eluting Stent Assembly Methods In force · Medium confidence | In force | Medium confidence | |
| US 10,137,015 | Knitted Stent Jackets In force · High confidence | In force | High confidence | |
| US 10,406,006 | Methods of Providing Optimized Drug-Eluting Stent Assemblies In force · Medium confidence | In force | Medium confidence | |
| US 9,132,261 | In Vivo Filter Assembly In force · Medium confidence | In force | Medium confidence | |
| US 10,376,393 | Stent Thermoforming Apparatus and Methods In force · High confidence | In force | High confidence |
Also on record, not counted in the 15: 5 patents ended · 8 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.